Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Confirm eligibility with your HSA/FSA plan administrator before paying, as rules vary by plan
Parkinsons disease: Trials ongoing All-Cause Mortality: Overall death rate: 10-15% reduction in high-risk populations
The number of pens you get depends on your dose
Symptoms of deep vein thrombosis (DVT) typically affect the legs and may include: Swelling in one leg, ankle, or foot Pain or tenderness, often starting in the calf Warmth in the affected area Red or discolored skin Unexplained leg pain, especially with unilateral symptoms Symptoms of pulmonary embolism (PE) , which occurs when a clot travels to the lungs, constitute a medical emergency and include: Sudden shortness of breath or difficulty breathing Sharp chest pain that worsens with deep breathing or coughing Rapid heart rate or palpitations Coughing up blood Lightheadedness or fainting Symptoms of arterial thrombosis (stroke or heart attack) require immediate emergency care: Sudden weakness or numbness, especially on one side of the body Difficulty speaking or understanding speech Sudden severe headache Chest pain, pressure, or discomfort Pain radiating to the arm, jaw, or back While these symptoms are not specifically associated with tirzepatide, any patient experiencing them should seek immediate medical evaluation regardless of their medication regimen
What if I experience severe nausea during dose escalation
This represents the highest weight loss ever recorded in a Phase 3 obesity trial, surpassing even the company's own dual agonist tirzepatide (Mounjaro/Zepbound), which achieved 22.5% in its pivotal studies
US$ 20.53
US$ 29.37
US$ 29.01
US$ 29.86
US$ 20.38
US$ 21.97
US$ 27.49
US$ 21.67
